TickerFacts.

Zhengye Biotechnology Holding Ltd (ZYBT): Gross Profit

Annual figures by period end, from SEC filings.

23.87M CNY
Year ended 2025-12-31
-45.6%
3-year compound annual growth
147.88M CNY2022-12-31: 147.88M CNY2023-12-31: 117.51M CNY2024-12-31: 91.30M CNY2025-12-31: 23.87M CNY23.87M CNY
2022-12-31 Gross Profit (CNY) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-3123.87M CNY-73.9%2026-04-28, From 2025-01-01
2024-12-3191.30M CNY-22.3%2026-04-28, From 2024-01-01
2023-12-31117.51M CNY-20.5%2026-04-28, From 2023-01-01
2022-12-31147.88M CNYn/a2025-07-03, From 2022-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Zhengye Biotechnology Holding Ltd (ZYBT)2025-12-3123.87M CNY-73.9%
Yatsen Holding Ltd (YSG)2025-12-313.36B CNY+28.4%

Compare ZYBT, YSG side by side · Screen every company in Pharmaceutical Preparations ↗